Contemporary Management of Stable Coronary Artery Disease
暂无分享,去创建一个
N. de Luca | C. Morisco | E. Barbato | J. Bartunek | B. De Bruyne | D. Bertolone | C. De Colle | C. Mancusi | M. Vanderheyden | D. Fabbricatore | C. Collet | E. Gallinoro | J. Sonck | N. Mileva | D. Munhoz | E. Wyffels | G. Esposito | P. Paolisso | Konstantinos Bermpeis | Chiara Valeriano | Marta Belmonte | M. Belmonte | N. De Luca | C. Valeriano | B. de Bruyne
[1] C. Berry,et al. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta‐Analysis , 2022, Journal of the American Heart Association.
[2] A. Editorial. Comments on the 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. , 2022, Revista espanola de cardiologia.
[3] M. Penicka,et al. Microvascular Dysfunction in Patients With Type II Diabetes Mellitus: Invasive Assessment of Absolute Coronary Blood Flow and Microvascular Resistance Reserve , 2021, Frontiers in Cardiovascular Medicine.
[4] A. Candreva,et al. Microvascular Resistance Reserve for Assessment of Coronary Microvascular Function: JACC Technology Corner. , 2021, Journal of the American College of Cardiology.
[5] I. V. Van Gelder,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2021, European heart journal.
[6] D. Perera,et al. Hyperemic hemodynamic characteristics of serial coronary lesions assessed by pullback pressure gradients , 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[7] A. Candreva,et al. Simplified Assessment of the Index of Microvascular Resistance , 2021, Journal of interventional cardiology.
[8] A. Candreva,et al. Basics of Coronary Thermodilution. , 2021, JACC. Cardiovascular interventions.
[9] ShengOlivia R. Liu,et al. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study , 2021, The Lancet.
[10] R. Gibbons,et al. Declining Accuracy of the Traditional Diamond-Forrester Estimates of Pretest Probability of Coronary Artery Disease: Time for New Methods. , 2021, JAMA internal medicine.
[11] P. Houthuizen,et al. High microvascular resistance and reduced left atrial strain in patients with coronary microvascular dysfunction: The micro-strain study. , 2021, International journal of cardiology.
[12] A. Candreva,et al. Thermodilution-Derived Volumetric Resting Coronary Blood Flow Measurement in Humans. , 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[13] J. Bartunek,et al. Duration of Hyperemia With Intracoronary Administration of Papaverine , 2021, Journal of the American Heart Association.
[14] K. Fox. Response by Fox to Letter Regarding Article, "The COMPASS Trial: Net Clinical Benefit of Low-Dose Rivaroxaban Plus Aspirin as Compared With Aspirin in Patients With Chronic Vascular Disease". , 2021, Circulation.
[15] Jun-Jie Zhang,et al. 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation. , 2020, JACC. Cardiovascular interventions.
[16] Steffen E. Petersen,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. , 2016, European journal of preventive cardiology.
[17] ESC / EAS Guidelines for the Treatment of Dyslipidemias: Lipid Modification to Reduce Cardiovascular Risk , 2020, Digital Doctor.
[18] D. Andreini,et al. Implementing Coronary Computed Tomography Angiography in the Catheterization Laboratory. , 2020, JACC. Cardiovascular imaging.
[19] H. Bøtker,et al. Validation of the European Society of Cardiology pre-test probability model for obstructive coronary artery disease. , 2020, European heart journal.
[20] Ulf J Jensen,et al. Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque. , 2020, Journal of the American College of Cardiology.
[21] Charles A. Taylor,et al. Non‐invasive procedural planning using computed tomography‐derived fractional flow reserve , 2020, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[22] A. Baumbach,et al. An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructive Coronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. , 2020, European heart journal.
[23] D. Wood,et al. Nonculprit Lesion Plaque Morphology in Patients With ST-Segment–Elevation Myocardial Infarction , 2020, Circulation. Cardiovascular interventions.
[24] Marco Valgimigli,et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.
[25] Deepak L. Bhatt,et al. Long-term ticagrelor for secondary prevention in patients with prior myocardial infarction and no history of coronary stenting: insights from PEGASUS-TIMI 54. , 2019, European heart journal.
[26] C. V. van Mieghem,et al. Graft patency after FFR-guided versus angiography-guided coronary artery bypass grafting. The GRAFFITI trial. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[27] E. Barbato,et al. Measurement of Hyperemic Pullback Pressure Gradients to Characterize Patterns of Coronary Atherosclerosis. , 2019, Journal of the American College of Cardiology.
[28] Deepak L. Bhatt,et al. Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial. , 2019, Lancet.
[29] M. Sabatine,et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. , 2019, European heart journal.
[30] Eloisa Arbustini,et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. , 2019, European heart journal.
[31] D. Glineur,et al. Impact of preoperative fractional flow reserve on arterial bypass graft anastomotic function: the IMPAG trial. , 2019, European heart journal.
[32] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[33] M. D. Di Carli,et al. Estimating Pre-Test Probability of Coronary Artery Disease: Battle of the Scores in an Evolving CAD Landscape. , 2019, JACC. Cardiovascular imaging.
[34] E. Prescott,et al. Prediction of obstructive coronary artery disease and prognosis in patients with suspected stable angina. , 2018, European heart journal.
[35] J. Andreasen,et al. Fractional Flow Reserve Versus Angiographically-Guided Coronary Artery Bypass Grafting. , 2018, Journal of the American College of Cardiology.
[36] Odyssey Outcomes Investigators. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome , 2018 .
[37] M. D. Di Carli,et al. Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.
[38] Thomas Kahan,et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.
[39] E. Barbato,et al. Six-Year Follow-Up of Fractional Flow Reserve-Guided Versus Angiography-Guided Coronary Artery Bypass Graft Surgery , 2018, Circulation. Cardiovascular interventions.
[40] Jeroen J. Bax,et al. The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability , 2018, European heart journal.
[41] G. Condorelli,et al. Direct Oral Anticoagulants in Addition to Antiplatelet Therapy for Secondary Prevention After Acute Coronary Syndromes: A Systematic Review and Meta-analysis , 2018, JAMA cardiology.
[42] P. Jüni,et al. Clinical Outcomes and Cost-Effectiveness of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease: Three-Year Follow-Up of the FAME 2 Trial (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation). , 2017, Circulation.
[43] Akiko Maehara,et al. Role of Low Endothelial Shear Stress and Plaque Characteristics in the Prediction of Nonculprit Major Adverse Cardiac Events: The PROSPECT Study. , 2017, JACC. Cardiovascular imaging.
[44] Deepak L. Bhatt,et al. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease , 2017, The New England journal of medicine.
[45] J. Fujimoto,et al. Clinical Significance of Lipid-Rich Plaque Detected by Optical Coherence Tomography: A 4-Year Follow-Up Study. , 2017, Journal of the American College of Cardiology.
[46] E. Omerovic,et al. Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI , 2017, The New England journal of medicine.
[47] A. Jeremias,et al. Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI , 2017, The New England journal of medicine.
[48] A. Keech,et al. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease , 2017, The New England journal of medicine.
[49] W. Koenig,et al. Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial. , 2016, JAMA.
[50] Patrizio Lancellotti,et al. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, European heart journal cardiovascular Imaging.
[51] Habib Samady,et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation (ILUMIEN III: OPTIMIZE PCI): a randomised controlled trial , 2016, The Lancet.
[52] J. Ottervanger,et al. Rationale and Design , 2022 .
[53] L. Räber,et al. Intracoronary imaging of coronary atherosclerosis: validation for diagnosis, prognosis and treatment. , 2016, European heart journal.
[54] J. Abdulla,et al. Characteristics of high-risk coronary plaques identified by computed tomographic angiography and associated prognosis: a systematic review and meta-analysis. , 2016, European heart journal cardiovascular Imaging.
[55] P. Stella,et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. , 2015, European heart journal.
[56] Francesco Versaci,et al. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study. , 2015, JACC. Cardiovascular imaging.
[57] Akiko Maehara,et al. Comparison of Stent Expansion Guided by Optical Coherence Tomography Versus Intravascular Ultrasound: The ILUMIEN II Study (Observational Study of Optical Coherence Tomography [OCT] in Patients Undergoing Fractional Flow Reserve [FFR] and Percutaneous Coronary Intervention). , 2015, JACC. Cardiovascular interventions.
[58] Matthias Gutberlet,et al. Clinical outcomes of fractional flow reserve by computed tomographic angiography-guided diagnostic strategies vs. usual care in patients with suspected coronary artery disease: the prospective longitudinal trial of FFRCT: outcome and resource impacts study , 2015, European heart journal.
[59] William Wijns,et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study , 2015, European heart journal.
[60] Scot-Heart Investigators,et al. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial , 2015, The Lancet.
[61] Marc P. Bonaca,et al. Long-term use of ticagrelor in patients with prior myocardial infarction. , 2015, The New England journal of medicine.
[62] E. Yow,et al. A selection of recent, original research papers , 2015, Journal of Nuclear Cardiology.
[63] Braunwald,et al. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. , 2014, The New England journal of medicine.
[64] D. Berman,et al. Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. , 2014, JACC. Cardiovascular imaging.
[65] B. Dimitrov,et al. Does Routine Pressure Wire Assessment Influence Management Strategy at Coronary Angiography for Diagnosis of Chest Pain?: The RIPCORD Study , 2014, Circulation. Cardiovascular interventions.
[66] Hiroshi Ito,et al. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). , 2014, Journal of the American College of Cardiology.
[67] Evelyn Regar,et al. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. , 2014, European heart journal.
[68] P. Serruys,et al. Natural history of optical coherence tomography-detected non-flow-limiting edge dissections following drug-eluting stent implantation. , 2014, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[69] T. Biering-Sørensen,et al. Myocardial Strain Analysis by 2-Dimensional Speckle Tracking Echocardiography Improves Diagnostics of Coronary Artery Stenosis in Stable Angina Pectoris , 2013, Circulation. Cardiovascular imaging.
[70] G. Mancia,et al. Clinical Management of Coronary Heart Disease in Hypertension , 2013, High Blood Pressure & Cardiovascular Prevention.
[71] Charles A. Taylor,et al. Computational fluid dynamics applied to cardiac computed tomography for noninvasive quantification of fractional flow reserve: scientific basis. , 2013, Journal of the American College of Cardiology.
[72] L. Wallentin,et al. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis , 2013, European heart journal.
[73] E. Picano,et al. Coronary flow reserve during dipyridamole stress echocardiography predicts mortality. , 2012, JACC. Cardiovascular imaging.
[74] Michail I. Papafaklis,et al. Prediction of Progression of Coronary Artery Disease and Clinical Outcomes Using Vascular Profiling of Endothelial Shear Stress and Arterial Plaque Characteristics: The PREDICTION Study , 2012, Circulation.
[75] C. Terkelsen,et al. Global left ventricular longitudinal systolic strain for early risk assessment in patients with acute myocardial infarction treated with primary percutaneous intervention. , 2012, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[76] N. Bruining,et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures , 2012, European heart journal.
[77] Erik Jørgensen,et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. , 2012, European heart journal.
[78] Paul Burton,et al. Rivaroxaban in patients with a recent acute coronary syndrome. , 2012, The New England journal of medicine.
[79] Helmut Baumgartner,et al. ESC / EACTS Guidelines on myocardial revascularization , 2014 .
[80] I. Meredith,et al. Computed tomography stress myocardial perfusion imaging in patients considered for revascularization: a comparison with fractional flow reserve. , 2012, European heart journal.
[81] A. Arbab-Zadeh,et al. Quantification of coronary arterial stenoses by multidetector CT angiography in comparison with conventional angiography methods, caveats, and implications. , 2011, JACC. Cardiovascular imaging.
[82] F. Alfonso,et al. Prospective application of pre-defined intravascular ultrasound criteria for assessment of intermediate left main coronary artery lesions results from the multicenter LITRO study. , 2010, Journal of the American College of Cardiology.
[83] B. Gersh,et al. Angiographic Versus Functional Severity of Coronary Artery Stenoses in the FAME Study: Fractional Flow Reserve Versus Angiography in Multivessel Evaluation , 2011 .
[84] Uwe Siebert,et al. Clinical ResearchInterventional CardiologyFractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease: 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study , 2010 .
[85] K. Oldroyd,et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. , 2010, Journal of the American College of Cardiology.
[86] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[87] Claes Held,et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. , 2009, The New England journal of medicine.
[88] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials , 2009, The Lancet.
[89] Jennifer G. Robinson,et al. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. , 2009, Journal of the American College of Cardiology.
[90] E. Antman,et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.
[91] M. Hunink,et al. Stress echocardiography, stress single-photon-emission computed tomography and electron beam computed tomography for the assessment of coronary artery disease: a meta-analysis of diagnostic performance. , 2007, American heart journal.
[92] O. Penn,et al. Does stenosis severity of native vessels influence bypass graft patency? A prospective fractional flow reserve-guided study. , 2007, The Annals of thoracic surgery.
[93] Diederick E Grobbee,et al. Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial. , 2007, JAMA.
[94] S. Nissen,et al. The ASTEROID trial: coronary plaque regression with high-dose statin therapy. , 2006, Future cardiology.
[95] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[96] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association , 2002, The international journal of cardiovascular imaging.
[97] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.
[98] M. Cerqueira,et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Circulation.
[99] P. R. R. Ecurrent,et al. EFFECTS OF CLOPIDOGREL IN ADDITION TO ASPIRIN IN PATIENTS WITH ACUTE CORONARY SYNDROMES WITHOUT ST-SEGMENT ELEVATION , 2001 .
[100] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.